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ABSTRACT: The type II dehydroquinase, which is an essential enzyme in Helicobacter pylori and 
Mycobacterium tuberculosis and does not have any counterpart in human cells, is recognized to be an 
attractive target for the development of new antibacterial agents. Computational and biochemical studies that 
help understand in atomic detail the catalytic mechanism these bacterial enzymes are reported. A previously 
unknown key role of certain conserved residues of these enzymes, as well as the structural changes 
responsible for triggering the release of the product from the active site were identified. Asp89*/Asp88* 
from a symmetry-related neighboring enzyme subunit proved to be the residue responsible for the 
deprotonation of the essential tyrosine to afford the catalytic tyrosinate, which triggers the enzymatic 
process. The essentiality of this residue is supported by results from site-directed mutagenesis. For 
Helicobacter pylori DHQ2, this reaction takes place through the assistance of a water molecule, while for 
Mycobacterium tuberculosis DHQ2, the tyrosine is directly deprotonated by the aspartate residue. The 
participation of a water molecule in this deprotonation reaction is supported by solvent isotope effects and 
proton inventory studies. Molecular dynamics simulation studies provide details of the required motions for 
the catalytic turnover, which provides a complete overview of the catalytic cycle. The product is expelled 
from the active site by the essential arginine and after a large conformational change of a loop containing 
two conserved arginines (Arg109/Arg108 and Arg113/Arg112), which reveals a previously unknown key 
role of these residues. These studies highlight the key role of the aspartate residue whose blockage could be 
useful in the rational design of inhibitors and the mechanistic differences between both enzymes. 
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INTRODUCTION   
The decreased effectiveness of antibacterial agents against infectious diseases caused by the development of 
drug resistance has become one of the most important public health issues of the early 21st century. Only 70 
years after the introduction of penicillin, we face the possibility of a future without effective antibiotics 
against several types of bacteria that cause infections in humans. Antibacterial drug resistance also has a 
huge economic and social impact [1,2]. Thus, the European Centre for Disease Prevention and Control 
(ECDC) estimates that antimicrobial resistance results each year in 25,000 deaths and related costs of over 
€1.5 billion in healthcare expenses and productivity losses. Despite the recognized need for new antibiotics, 
only two new classes of antibiotics have been brought to the market in the last three decades and there are 
only a few antibacterial agents under development to face the challenge of multidrug resistance [3-5]. 
Therefore, the discovery of novel drugs and therapies to treat antibiotic-resistant infections and, particularly 
of drugs with new mechanisms of action is needed. In this context, there is a great and increasing interest in 
the detailed knowledge of the catalytic mechanism of selected enzymes for the rational design and 
development of new inhibitors that can be used as drugs. However, enzymes are very complex entities, and 
in many cases it is difficult to establish precisely how they perform only on the basis of biochemical and 
structural data. In recent years, computational methods have consolidated their value as important 
complementary tools that can assist in the elucidation of how these reactions are catalyzed [6-8]. Here we 
report results from computational and biochemical studies that help understand in atomic detail the catalytic 
mechanism of two essential bacterial enzymes that are recognized to be attractive targets for the 
development of new antibacterial agents [9]. 
 
These studies also allowed us to identify a previously unknown 
key role of certain conserved residues as well as the structural changes responsible for triggering the release 
of the product from the active site. This information could be very useful for structure-based inhibitor 
design. 
During the past few years, a great deal of effort has been focused on the development of new antibacterial 
agents that inhibit the enzymes involved in the shikimic acid pathway, in which chorismic acid is 
synthesized. This compound is the precursor of aromatic amino acids and other metabolites, including 
folates, ubiquinone, and vitamins E and K [10]. This biosynthetic route is present in bacteria, fungi, higher 
plants and certain apicomplexan parasites, which are the cause of malaria and toxoplasmosis [11]. The fact 
that it does not have any counterpart in human cells makes this pathway an attractive target for the 
development of herbicides and antimicrobial agents. We have focused on the inhibition of the third enzyme 
of the pathway, the type II dehydroquinase (3-dehydroquinate dehydratase, EC 4.2.1.10, DHQ2), one of the 
two known DHQ enzymes, because it is essential in important pathogenic bacteria such as Mycobacterium 
tuberculosis (aroD gene, Mt-DHQ2) [12], responsible for causing tuberculosis, and Helicobacter pylori 
(aroD/aroQ gene, Hp-DHQ2) [12], the causative agent of gastric and duodenal ulcers, which has also been 
classified as a type I carcinogen. 
DHQ2 catalyzes the reversible dehydration of 3-dehydroquinic acid (1) to form 3-dehydroshikimic acid (2) 
by the anti elimination of water involving the loss of the more acidic pro-S hydrogen from C2 of 1 (Scheme 
1).
 
DHQ2 is a dodecamer formed from a tetramer of trimers, a trimer being the minimum catalytic unit of 
the enzyme [13]. After substrate binding, a flexible loop forms a lid that closes the active site. Two residues, 
an arginine (Arg17/Arg19 in Hp-DHQ2 and Mt-DHQ2, respectively) and a tyrosine (Tyr22/Tyr24 in Hp-
DHQ2 and Mt-DHQ2, respectively), both located in the flexible loop, were identified by chemical 
modification and site-directed mutagenesis studies as essential for enzyme activity [14,15]. In the absence of 
structural data, earlier kinetic isotope effects and pH profile studies carried out on Mt-DHQ2 and Aspergillus 
nidulans DHQ2 (An-DHQ2) suggested that the elimination proceeds by a stepwise E1CB mechanism 
involving an enolate intermediate 3 (Scheme 1) [16]. Subsequent crystallization and resolution of the DHQ2 
from Streptomyces coelicolor (Sc-DHQ2) by Lapthorn et al. [17] allowed a detailed description of the active 
site and the assignment of specific functions to individual amino acid residues. In particular, an important 
part of the substrate recognition site is the carboxylate binding pocket that gives rise to four strong hydrogen 
bonding interactions involving the main chain amide NH groups of Leu102 and Thr102, the side chain OH 
group of Thr102 and the side chain amide of the conserved Asn76 [18]. 
 
In addition, the latter residue also 
acts in correctly positioning the C1 hydroxyl group to accept a proton from the conserved histidine 




initiated by the essential tyrosine of the active site removing the pro-S hydrogen from C2 of 1 whereas the 
final step is the acid-catalyzed elimination of the C1 hydroxyl group ‒ a reaction mediated by the conserved 
histidine acting as a proton donor. The reduced pKa of the essential tyrosine arises from the basic 
environment formed by the conserved arginine of the active site (Arg109/Arg108 in Hp-DHQ2 and Mt-
DHQ2, respectively). Molecular dynamics (MD) simulation studies suggested that the essential arginine side 
chain located on the loop must be close to the essential tyrosine side chain for catalysis [19]. Under this 
arrangement, the arginine controls the appropriate orientation of the tyrosine roughly perpendicular to the 
cyclohexane ring of the natural substrate by a cation- interaction and contributes to decreasing the pKa of 
the phenol ring to about 7 [19]. 
Due to the absence of any suitable residue that could stabilize an enolate intermediate and the presence of a 
conserved active site water molecule (henceforth WAT1) in Sc-DHQ2 crystal structures, Lapthorn et al. [17] 
suggested the formation of the enol intermediate 4 rather than the enolate intermediate 3 (Scheme 1). This 
water molecule interacts through hydrogen-bonding with a conserved asparagine (Asn10/Asn12 in Hp-
DHQ2and Mt-DHQ2, respectively), the carbonyl group of a conserved proline (Pro9/Pro11 in Hp-DHQ2 
and Mt-DHQ2, respectively), and the main chain amide of a glycine or an alanine (Ala79/Gly78 in Hp-
DHQ2 and Mt-DHQ2, respectively). On the basis of these structural considerations, the authors proposed 
that the enol intermediate 4 is formed upon proton transfer from WAT1 assuming that the side chain of a 
conserved asparagine (Asn10/Asn12 in Hp-DHQ2 and Mt-DHQ2, respectively) would be deprotonated by 
this water molecule. Later on, Blomberg et al. [20], considering the high energy required to deprotonate the 
side chain of an asparagine and on the basis of results from quantum mechanical (QM) calculations using 
different Hamiltonians on Sc-DHQ2, suggested the formation of enolate intermediate 3 because of its 
significantly lower energy compared to that of enol intermediate 4. Even though the reaction mechanism is 
generally well understood, there are still some unsolved issues, mainly regarding how the catalytic form of 
the essential tyrosine (tyrosinate) is formed and the discrepancy in the mechanisms comparing DHQ2 from 
different sources to explain previously reported solvent isotope effects (mainly with Mt-DHQ2 and An-
DHQ2) [16]. In addition, a more detailed knowledge of the role(s) of the essential arginine also located in 
the flexible loop is required. 
To gain further insight into these unanswered questions and to improve our understanding of the catalytic 
mechanism of both Hp-DHQ2 and Mt-DHQ2 in atomic detail, computational and biochemical studies were 
undertaken including site-directed mutagenesis, solvent isotope effects and proton inventories. For the 
computational studies, we used a combination of standard MD simulations on a catalytically active trimer in 
aqueous solution, using the molecular mechanics force field AMBER [21], and hybrid QM/MM calculations 
inside the active site, using density functional theory (DFT). The main advantage of this latter approach, 
which is implemented in the AMBER 12 release, over previous QM studies that focused on simplified 
model systems is that bond making and breaking are possible in a dynamic context and also that 
reorganization of active site residues, substrate, and water molecules is realistically allowed during the 
whole reaction coordinate. The studies described here identified the residue that deprotonates the essential 
tyrosine that triggers the DHQ2 catalytic process, whose essentiality is supported by results from site-
directed mutagenesis. This allowed us to report a previously unnoticed key role for the conserved residue 
Asp89*/Asp88* (in Hp-DHQ2 and Mt-DHQ2, respectively) from a symmetry-related neighboring enzyme 
subunit (residues from this subunit will be marked with an asterisk). This residue was previously thought to 
play only a structural role because it is involved in the formation of a salt bridge with the guanidinium of the 
conserved Arg113/Arg112 (in Hp-DHQ2and Mt-DHQ2, respectively) and of a hydrogen bond with the C4 
hydroxyl group of the substrate [17]. In addition, the studies reported here show the required enzymatic 
motions for catalytic turnover and also identify a key role of the essential arginines Arg17/Arg19 and 
Arg109/Arg108 in product release. 
 
EXPERIMENTAL 
Generation and minimization of the Michaelis complex 
a) Helicobacter pylori DHQ2 model: These studies were carried out using the enzyme coordinates found in 




methoxybenzyl)-3-dehydroquinic acid (PDB code 2XB9) [19] that co-crystallized with three copies of the 
monomer in the asymmetric unit (designated as chains A, B and C). Chains A and B contain the inhibitor 
and chain C has citrate originating from the enzyme crystallization buffer as in PDB entry 2C4V [22]. The 
citrate-bound chain C was used to create a trimer after superimposition to chains A, F and G of Mt-DHQ2 in 
complex with its reaction product (PDB code 3N59) [23].  
a) Mycobacterium tuberculosis DHQ2 model: Simulations were carried out using the enzyme coordinates 
found in the crystal structures of Mt-DHQ2 in complex with either (2S)-2-(perfluorobenzyl)-3-
dehydroquinic acid (PDB code 4B6P, model 1)
 
[24] or 3-dehydroshikimic acid (2) (PDB code 3N59 [23], 
model 2). These binary complexes contain a single Mt-DHQ2 molecule in the crystallographic asymmetric 
unit. For model 1, the trimer was created from this monomer after superimposition to chains B, C and E of 
Mt-DHQ2 in complex with 3-dehydroshikimic acid (2) (PDB code 3N59 [23]). Both models provided 
similar results for the first reaction coordinate but model 2 gave results for the dehydration step that were in 
better agreement with the experimental data. 
For all the binary complexes, the substrate was manually docked into the active site. No crystallographic 
water molecules were maintained except for the conserved water molecule (WAT1). Addition of missing 
hydrogen atoms and computation of the protonation state of titratable groups at pH 7.0 were carried out 
using the H++ Web server [25,26], which relies on AMBER [21] force-field parameters and finite difference 
solutions to the Poisson-Boltzmann equation
 
[27] δ and/or ε protonation was manually corrected for 
His102/His101 (dual) residues due to mechanistic considerations and on the basis of results from 
preliminary MD simulations. The charge distribution for each ligand studied was obtained by fitting the 
quantum mechanically calculated (RHF/6-31G*//B3LYP/cc-pVTZ and IEF-PCM as solvation model) 
molecular electrostatic potential (MEP) of the geometry-optimized molecule to a point charge model, as 
implemented in Gaussian 03 and 09 [28]. The general AMBER force field, GAFF [29], was used to assign 
bonded and nonbonded parameters (parm03) to 3-dehydroquinic acid (1) atoms. 
Molecular dynamics simulations 
Each molecular system was immersed in a truncated octahedron containing TIP3P water molecules [30] and 
Na
+
 ions [31] to achieve electroneutrality (~30,000 water molecules and 16 Na
+
 ions for Hp-DHQ2 model, 
~14,200 water molecules and 15 Na
+
 ions for model 1 of Mt-DHQ2 and ~20,000 water molecules and 21 
Na
+
 ions for model 2 of Mt-DHQ2). The sander and pmemd modules from the AMBER 12
 
[32] suite were 
used for the restrained and unrestrained MD simulations, respectively. Periodic boundary conditions were 
applied and electrostatic interactions were treated using the smooth particle mesh Ewald (PME) method
 
[33] 
with a grid spacing of 1 Å. The cutoff distance for the nonbonded interactions was 9 Å, the SHAKE
 
[34] 
algorithm was applied to all bonds and an integration step of 2.0 fs was used throughout. After an initial 
energy minimization of the water molecules and counterions, the system was heated to 300 K in 25 ps. Then 
it was equilibrated by first allowing the solvent to redistribute around the positionally restrained solute for 
220 ps; after this time, the system was allowed to evolve freely without restraints so as to explore the mutual 
adaptation between ligand and enzymes. Snapshots from the 10 ns MD trajectory were collected every 20 
ps. 
Hybrid QM/MM calculations 
Classical molecular mechanics (MM) methods lack the ability to treat fundamentally electronic processes 
such as bond breaking/forming and charge fluctuations as a function of geometry
 
[35] but it is possible to 
treat a subsection of the system quantum mechanically (QM) and use a coupling potential to connect the 
MM and QM regions. This hybrid QM/MM approach is seamlessly integrated in the sander module of 
AMBER 12
 
[32] and also includes a complete treatment of long-range electrostatics by using a QM/MM 
modified PME method. The QM region, defined by the iqmatoms keyword, encompassed the active site 
region where bonds are broken and formed, and the MM region included all the remaining protein, solvent 
atoms and counterions. Care was taken not to cut any polarizable bonds when defining the QM/MM 
boundary. Thus, the QM region contained the whole of the natural substrate and the following side chains 
residues: a) for the Hp-DHQ2 enzyme, the side chains of Asn10, Tyr22, Asn76, His82, His102, Thr104 
(starting at Cβ), Arg17, Arg109 and Arg113 (starting at C) of the central subunit, and Asp89* of the 




enzyme, the side chains of Asn12, Tyr24, Asn75, His81, His101, Ser103 (starting at Cβ), Arg19, Arg108 
and Arg112 (starting at C) of the central subunit, and Asp88* of the neighboring subunit and the structural 
water molecule WAT1. We selected the Density Functional Tight-binding method (DFTB)
 
[36] and full 
electrostatic interactions between the QM charge density and the point charges of the MM atoms. To 
proceed with abstraction of the C2 axial hydrogen of 1, the active site region of each solvated complex was 
subjected to a QM treatment during the course of a steered 10-ps MD simulation [37]. For Hp-DHQ2, three 
double reaction coordinates were defined for simultaneously shortening the (WAT2)-H–(Asp89*)-O, 
(WAT2)-O–(Tyr22)-H and (Tyr22)-O–(1)-H2ax distances while stretching the (WAT2)-H–(WAT2)-O, 
(Tyr22)-H–(Tyr22)-O and (1)-H2ax–(1)-C2 bonds. For Mt-DHQ2, two double reaction coordinates were 
defined for simultaneously shortening the (Asp88*)-O(Tyr24)-H and (Tyr24)-O–(1)-H2ax distances while 
stretching the (Tyr24)-H–(Tyr24)-O and (1)-H2ax–(1)-C2 bonds (see Supplementary Online Data). 
Dehydratation of 3 through His102
+
 deprotonation was achieved by elongating the covalent bond between 





 was used in all the reaction coordinates. During the QM/MM part of the MD simulation 
SHAKE for the QM region (keyword qmshake) was turned off and the integration step was reduced to 0.5 
fs. The molecular graphics program PyMOL [38] was employed for visualization and model building. 
Interatomic distances were monitored by using the ptraj module in AMBER. 
Site-directed mutagenesis 
The DNA sequences encoding variant forms of the Mt-DHQ2 in which Asp88* was replaced by Asn and 
Asn12 was replaced by Ser were synthesized by the company GeneArt, and subcloned into the E. coli 
expression vector pET21a to yield plasmids pMUT308 and pMUT309, respectively.  
Protein production and purification of variant proteins 
E. coli strain BL21 DE3 was transformed singly each plasmid and transformats were selected on 100 µg mL
-
1
 ampicillin. The transformed strains were grown in drug supplemented Luria Broth at 37 
o
C until an 
attenuance of 0.6. Uppon addition of 0.2 mg mL
-1
 IPTG, incubation continued for a further 5 h. After 
harvesting by centrifugation, 50g cells producing D88N or N12S were disrupted by sonication in 50 mM 
potassium phosphate buffer pH 7.2, 1 mM DTT, 1 mM benzamidine (buffer 1) and centrifuged at 10,000xg 
for 40 min. The supernatants were applied to Q Sepharose columns (5×15 cm) and were washed with 1.0 L 
of 50 mM potassium phosphate buffer pH 7.2, 1 mM DTT (buffer 2). The columns were then eluted with a 
NaCl gradient (1 L, 0 to 1 M) in buffer 2 collecting 10 mL fractions. DHQ2-encoding fractions were 
identified by direct assay and SDS PAGE and pooled appropriately. After dialysis into 2×5 L changes of 50 
mM potassium phosphate buffer pH 6.6, 1 mM DTT (buffer 3), the D88N and N12S variant proteins were 
loaded onto hydroxyapatite (5×7.5 cm) columns and washed with 500 mL of buffer 4. The columns were 
then eluted with a gradient of potassium phosphate buffer pH 6.6 containing 1 mM DTT (1 L, 50 to 400 
mM). For N12S protein, DHQ2-encoding fractions were identified by direct enzyme assay and SDS PAGE 
and pooled appropriately, yielding approximately 300 mg of N13S variant protein of at least 95% purity. For 
the D88N protein, DHQ2-encoding fractions were identified by SDS PAGE and pooled appropriately. D88N 
protein was then dialysed against 2×5 L changes of 50 mM potassium phosphate buffer pH 6.0, 1 mM DTT 
(buffer 4) and chromatographed on a MONO Q 10/100 GL FPLC column. Following a 3 column volume 
wash, protein was eluted by a 20 column volume 01.0 M NaCl gradient in buffer 4. The flow rate was 0.5 
mL min
-1
 and the fraction size was 0.5 mL. This procedure yielded approximately 60 mg of D88N protein at 
greater than 95% purity. 
Enzyme assay conditions 
Wild-type Hp-DHQ2, Sc-DHQ2 and Mt-DHQ2 enzymes were purified as described previously [39,40].
 
Concentrated solutions of Hp-DHQ2 (6.4 mg mL
-1
) were stored in potassium phosphate buffer (50 mM, pH 
7.2), DTT (1 mM) and NaCl (150 mM) and Sc-DHQ2 (5 mg mL
-1
) in Tris HCl (20 mM, pH 7.5) and DTT 
(0.5 mM), respectively. When required for assays, aliquots of the enzyme stocks were diluted in water and 
buffer and stored on ice.
 
DHQ2 was assayed in the forward direction by monitoring the increase in 
absorbance at 234 nm in the UV spectrum due to the absorbance of the enone-carboxylate chromophore of 




or Tris HOAc (50 mM). Each assay was initiated by addition of the substrate. Solutions of 3-dehydroquinic 
acid (1) were calibrated by equilibration with DHQ2 and measurement of the change in the UV absorbance 
at 234 nm due to the formation of the enone-carboxylate chromophore of 3-dehydroshikimic acid (2). The 
initial rates at fixed enzyme and substrate concentrations (0.2–5 Km) were measured. Kinetic constants were 
evaluated using the GraFit 5 program (Erithacus Software Ltd.). 
Solvent isotope effects 




H Tris-chloride buffer solutions 
at pH or p
2
H 7.0 over a range of substrate concentrations (0.2–5 Km). Deuterated Tris-chloride buffer was 
prepared from commercially available 1 M Tris-d11 solution in 
2
H2O with 98% deuterium content, 
2
H2O 
with 99.9% deuterium content and deuterium chloride solution 35 wt.% in 
2
H2O with 99% deuterium 
content, all purchased from Sigma-Aldrich. The p
2
H was calculated by adding 0.4 to the electrode reading. 
Proton inventory 
The proton inventory studies were performed in isotopic buffers at a range of molar fraction of deuterium (n) 
from 0–1 under Vmax conditions (see Supplementary Online Data) [41]. Buffers in isotopic mixtures of water 




H2O and the isotopic dilution of the 
2
H2O solutions was not considered when calculating the 





In the Hp-DHQ2 Michaelis complex, after system equilibration a water molecule from the bulk solvent 
(henceforth WAT2) entered the active site and remained fixed between the side chain of Asp89* and Tyr22 
(Figure 1), with one of its protons engaged in a hydrogen bond with a carboxylate oxygen of Asp89* and 
one of its oxygen’s lone pairs accepting a hydrogen bond from the guanidinium group of Arg109. As a 
result, the orientation of the other lone pair was locked towards the phenolic proton of Tyr22 whereas the 
phenolic oxygen was placed at an average distance of 2.0 Å from the axial hydrogen at C2 of 1. Besides, a 
number of strong and highly directional electrostatic interactions were established (Figure 2 and 
Supplementary Online Data). Most importantly, the Asp89* carboxylate oxygen binding WAT2 was firmly 
held in position by two hydrogen bonds established with the guanidinium group of Arg113 whereas the other 
one was hydrogen bonded to the guanidinium group of the essential Arg17 and the amide of Asn10, which in 
turn was held in place by WAT1. We considered this architecture of the Hp-DHQ2 Michaelis complex, 
which remained stable during the MD simulation, as ideal for initiation of the reaction coordinate using the 
hybrid QM/MM method. 
In contrast, in the simulation of the Michaelis Mt-DHQ2 complex, a fixed water molecule between Asp88* 
and Tyr24 was not observed during the simulation. Instead, Tyr24 was found to be sufficiently close to 
Asp88* to effect a direct deprotonation. We believe that these differences arise from the distinct flexibilities 
and motions of the two Tyr-containing loops, which we have studied in detail in the two enzymes over the 
years [24]. Compared to Hp-DHQ2, this system proved to be somewhat less stable. In particular, significant 
changes in the relative distances between the phenolic oxygen of Tyr24 and the C2 axial hydrogen atom of 1 
and between the Asp88* carboxylate and the guanidinium group of Arg19 were observed. This finding is not 
surprising considering that this carboxylate is held in place by the arginine but at the same time needs to get 
close enough to the tyrosine to abstract the proton so that the ensuing tyrosinate will remove the C2 axial 
hydrogen of 1 (Figure 2). Apart from these differences, the substrate interacts with the enzyme active site 
making use of the same type of strong hydrogen bonding interactions with the key residues of the active site 
(see Supplementary Online Data). Several snapshots from the simulation were chosen as starting points to 
study the reaction mechanism using the hybrid QM/MM method, namely those with the shortest distances 
between the phenolic oxygen of Tyr24 and the C2 axial hydrogen and between the carboxylate oxygen of 






For Hp-DHQ2, the first reaction coordinate led to a neutral carboxylic group in the side chain of Asp89* 
upon capture of one of the WAT2 protons and the regeneration of WAT2 with the proton transferred from 
Tyr22, which in turn abstracted the C2 axial hydrogen of 1 and maintained the πcation interaction with the 
planar guanidinium moiety of Arg17 (Figures 1 and 2). This positively charged group also stabilized the 
enolate intermediate 3 through electrostatic interactions. In the resulting complex, WAT2 accepted a 
hydrogen bond from Arg109 and the protonated Asp89* had its orientation stabilized by Arg17 as well. The 
enolate intermediate 3 displayed a C-OH bond at C1 that was ~0.1 Å longer than the rest of C-OH bonds 
present in the substrate, and one of the lone pairs of the oxygen in the C1 hydroxyl group was oriented 
towards the N proton of His102. The electrostatic interaction between the hydrogen of the leaving OH and 
the side chain of Asn76 also favors this geometry as it locks the orientation of the oxygen lone pair.  
For Mt-DHQ2, direct removal of the Tyr24 proton by Asp88* followed by abstraction of the C2 axial 
hydrogen of 1 by the tyrosinate led to enolate 3 (Figures 2 and 3).
 
For both enzymes, the enolate was 
engaged in a strong electrostatic interaction with the guanidinium group of Arg19/Arg17 and also in a good 
hydrogen bond with WAT1 (see Supplementary Online Data). Moreover, when the DHQ2/3 binary complex 
was subjected to 10 ns of MD simulation, those interactions remain stable during the whole simulation and 
in addition, after 0.6 ns of MD simulation, the neutral Asp89*/Asp88* rotates to establish a hydrogen bond 
interaction with the enolate 3 (1.52.0 Å) that remains stable after that (see Supplementary Online Data). 
However, under similar conditions, the DHQ2/4 binary complex in which the enol intermediate 4 is formed 
after deprotonation of the neutral Asp89*/Asp88*, the guanidinium group of Arg19/Arg17 and 
Asp89*/Asp88* rapidily moves away from enol 4 (> 3 Å, see Supplementary Online Data). 
In line with previous proposals [16,20], our studies also suggested that enolate formation is the rate-
determining step as the calculated energy barrier obtained for this reaction was 13.9 and 19.7 kcal mol
-1
, 
which compares well with the experimentally measured and rate-determining barrier of 17.4 and 16.5 kcal 
mol
-1
 [42], for Hp-DHQ2 and Mt-DHQ2, respectively. 
Enolate dehydration and product formation 
Upon elongation of the covalent bond between C1 and the OH oxygen, the natural evolution of both systems 
was the spontaneous abstraction of the His102/His101 N proton and formation of the leaving water 
molecule. As a result, 3-dehydroshikimic acid (2) was formed and the carboxylate binding site geometry was 
structurally reorganized because the C1 hybridization changed from tetrahedral sp
3
 to planar sp
2
. As will be 
discussed below, this change does not appear to be the driving force for product release, contrary to earlier 
suggestions [17]. The calculated energy barriers for the dehydration step were 7.7 and 10.3 kcal mol
-1
 for 
Hp-DHQ2 and Mt-DHQ2, respectively.  
Product release 
In order to complete the catalytic cycle, two possibilities were then considered: (1) proton transfer from the 
neutral carboxylic acid of Asp89*/Asp88* to a water molecule (WAT2 in Hp-DHQ2), followed by product 
release, or (2) the reverse order. However, when the resulting DHQ2/2 binary complexes containing 
Asp89*/Asp88* as a carboxylate were subjected to 10 ns of standard MD simulation, no significant motions 
of the reaction products were observed (see Supplementary Online Data). 
Despite the aforementioned change of hybridization at the C1 position in 2, the carboxylate group 
maintained four strong hydrogen bonds with the enzyme, namely, with the main chain NH groups of Thr104 
and Leu103 and the side chains of Asn76 and Thr104. Furthermore, the enzyme snugly accommodated a 
water molecule, which was exchanged with other water molecules from the bulk solvent, in this part of the 
active site by bridging His101 and Asn76 residues (see Supplementary Online Data). Both facts provided a 
very stable Hp-DHQ2/2 binary complex during the 10 ns of MD simulation. However, under the same 
conditions, in the Mt-DHQ2/2 complex containing the neutral Asp88* side chain, the guanidinium moiety of 
Arg112 was expelled from the active site (up to ~6.4 Å) and that of the essential Arg19 moved toward the 
C1 carboxylate (Figure 4b). In order to evaluate whether these structural changes could be responsible for 
triggering product release from the active site and to get further details of the process, this complex was 




The results obtained showed that the large displacement of residues 101112 and 126130 (by up to 6.4 and 
8.3 Å, respectively) containing H2 and H3 310 helix and the conserved Arg108, Glu109 and Arg112 residues 
and the electrostatic interaction of the guanidinium group of Arg19 by pulling on the carboxylate group in 2, 
were responsible for breaking the favorable interactions of 2 with the active site residues, particularly the 
stabilizing hydrogen bonds with Asn76, Thr104 and Leu103 residues. As a result, the product would then be 
released from the active site through the cavity lined by the side chains of Leu16 and Ile102. With the 
product on the way out of the active site, the large loop containing H2 and H3 310 helix recovers its position. 
Moreover, the proton transfer reaction from the neutral carboxylic acid of Asp89*/Asp88* to a water 
molecule might take place after disruption of the product interactions with the C1 carboxylate binding site. 
Biochemical Studies  
To get further evidence supporting the key role of Asp89*/Asp88* in the generation of the catalytic 
tyrosinate and the conserved asparagine, Asn10/Asn12, in the stabilization of the protonated Asp89*/Asp88* 
during the enolate generation step rather than in engagement in a hydrogen bonding interaction with the 
conserved water molecule WAT1, site-directed mutagenesis experiments were carried out. Moreover, to 
demonstrate that deprotonation of the essential tyrosine in Hp-DHQ2 is assisted by a water molecule, 
solvent isotope effects and proton inventory studies were performed. 
Asn12 and Asp88* of Mt-DHQ2 were replaced by serine and asparagine residues, respectively. The kinetic 
parameters of both variants, N12S and D88N, were determined and compared to those measured for the 
wild-type enzyme (Table 1). When the kinetic parameters of both enzyme variants were determined at pH 7 
and compared to those measured for the wild-type enzyme, the N12S variant proved to have a similar Km 
value but a much smaller kcat whereas the acitivity of the D88N variant was dramatically reduced to less than 
0.05% that of the wild-type protein. Evaluation of the D88N variant in a pH range between 7.0 and 9.0 and 
using large amounts of the variant protein (20 units) showed some residual enzymatic activity at pH of 
7.88.2 whereas no uncatalyzed reaction was observed under these conditions. At pH 8.0, a Km more than 
one order of magnitude larger than the wild-type enzyme and a severely decreased kcat value were found 
(Table 1). In addition, in order to discard that the inactivity of D88N variant was due to a destabilization of 
its quaternary structure, this protein was analyzed by dynamic light scattering and by size exclusion 
chromatography and compared with the N12S variant (see Supplementary Online Data). The results showed 
that the N12S variant is a dodecamer whereas D88N is a trimer.  
Solvent isotope effects were determined on Vmax and Vmax/Km for Hp-DHQ2 and Sc-DHQ2 (Table 2). These 
enzymes proved to have a large solvent isotope effect on Vmax and Vmax/Km, being the latter smaller than for 
An-DHQ2. Moreover, in order to get more information regarding the number of hydrogenic sites 
contributing to the observed solvent isotope effects on Vmax proton inventory studies were carried out (see 
Supplementary Online Data). The results showed that, for Hp-DHQ2, there are at least two protons involved 
in the reaction, one associated with the elimination step and another/others involved in tyrosine 
deprotonation, in agreement with the QM/MM proposal that a water molecule assists in Tyr deprotonation. 
On the contrary, for Mt-DHQ2, there is a single proton contributing to the observed solvent [13], showing 
that this reaction is not assisted by a water molecule. 
DISCUSSION 
The catalytic mechanism of H. pylori and M. tuberculosis DHQ2, the third enzyme of the shikimic acid 
pathway and an essential enzyme in these pathogenic bacteria, has been studied in atomic detail by means of 
a hybrid QM/MM approach. A combination of standard MD on a catalytically active trimer in aqueous 
solution, using the MM force field AMBER in a box of water molecules and counterions, and QM DFT 
inside the active site during the course of several steered MD trajectories has allowed us to gain unique 
insight into the reaction mechanism. 
Given that the minimum catalytic unit of DHQ2 was experimentally determined to be a trimer [13], the latter 
was used for modeling and simulating first the Michaelis complexes with 3-dehydroquinic acid (1) and then 
the reaction to form 3-dehydroshikimic acid (2). In addition, previous MD simulation studies suggested that 
the essential arginine side chain must be close to the essential tyrosine side chain for catalysis because under 
this arrangement, it controls the appropriate orientation of the tyrosine roughly perpendicular to the 




the phenol ring [19]. Taking this into account, crystal structures of both enzymes with the two essential 
residues, Arg17/Arg19 and Tyr22/Tyr24, together pointing towards the active site were chosen. In particular, 
the Hp-DHQ2 Michaelis complex was generated using the enzyme geometries found in chain C of PDB 
2XB9 [19]. For the Mt-DHQ2 Michaelis complex, two models were evaluated using the enzyme coordinates 
found in the crystal structures of Mt-DHQ2 in complex with either (2S)-2-(perfluorobenzyl)-3-
dehydroquinic acid (PDB code 4B6P, model 1)
 
[24] and 3-dehydroshikimic acid (2) (PDB code 3N59 [23], 
model 2). Both models provided similar results for the first reaction coordinate but model 2 gave results for 
the dehydration step that were in better agreement with the experimental data. 
For the deprotonation of the essential tyrosinate and on the basis of the MD simulation studies carried out 
with the Hp-DHQ2 and Mt-DHQ2 Michaelis complexes, Asp89*/Asp88* and the essential Arg17/Arg19 
were considered as the general base involved in the enzymatic mechanism. However, the latter posibility 
was discarded based on the extremely high calculated energy barriers required (over 40 kcal mol
-1
, see 
Supplementary Online Data) compared with the obtained with Asp89*/Asp88* as the general base (see 
Results section). Furthermore, for the generation of the reaction intermediate, two possible mechanisms 
were assessed, thus, a two-step mechanism involving the generation of the catalytic tyrosinate followed by 
abstraction of the C2 axial hydrogen of 1 by the tyrosinate and a single-step mechanism. The lower 




which compares well with the 
experimentally measured and rate-determining barrier of 17.4 and 16.5 kcal mol
-1
 [42], for Hp-DHQ2 and 
Mt-DHQ2, respectively, suggested a concerted mechanism for the generation of the reaction intermediate. 
For both enzymes, the enolate 3 was engaged in a strong electrostatic interaction with the guanidinium 
group of Arg19/Arg17 and also in a good hydrogen bond with WAT1 and the neutral Asp89*/Asp88*. The 
results from the MD simulation studies carried out with the DHQ2/3 and DHQ2/4 binary complexes 
suggested that the strong and efficient electrostatic interaction between enolate 3 with the guanidinum group 
of Arg19/Arg17 is key in the stabilization of this charged intermediate. 
The alternative mechanism in which the neutral Asp88*/Asp89* could protonate the enolate intermediate 3 
to afford enol intermediate 4 was also studied. However, the energy barrier of the subsequent dehydration 
step was calculated to be much higher. The formation of an enol 4 vs enolate 3 was also previously studied 
by Blomberg et al. [20]. In this case, formation of 4 was studied upon proton transfer from WAT1 assuming 
that the side chain of a conserved asparagine (Asn10/Asn12) would be deprotonated by this water molecule 
as previously suggested by Lapthorn et al. [17]. The authors considering the high energy required to 
deprotonate the side chain of an asparagine and on the basis of results from QM calculations, suggested the 
formation of enolate intermediate 3 because of its significantly lower energy compared to that of 4. We have 
found the same results as Blomberg et al. [20 considering a proton transfer from neutral Asp88*/Asp89*. 
Due to the limited repertoire of titratable groups, proteins can activate these residues as nucleophiles, 
electrophiles, general-base or general-acid catalysts as a direct result of the microenvironment created 
around the functional group [43]. There are numerous examples of ionizable groups with highly perturbed 
pKa values [44]. For instance, a good example of an enzyme with a perturbed Tyr and Asp in the active site, 
as might occur for the DHQ2 enzyme, is ketosteroid isomerase, in which an active site aspartate (Asp38, 
pKa 9.5) acts as a general base and removes the ketone -hydrogen atom of the substrate (pKa 12.7) [45-
47]. The reaction catalysed by this enzyme also involves a tyrosine with a highly perturbed pKa value [43]. 
In the DHQ2 enzymes, the proximity of the conserved Arg108/Arg109 residue and the cation-π interaction 
with the essential Arg19/Arg17 would be expected to have a significant effect on the pKa of Tyr22/Tyr24, as 
was previously suggested by Lapthorn et al. [17]. This fact was the basis of several substrate analogs 
developed in our research group that still have the axial hydrogen to be removed by the enzyme. These (2R)-
2-benzyl-3-dehydroquinic acids proved to be nanomolar reversible competitive DHQ2 inhibitors [19, 24]. 
The benzyl group of those inhibitors prevent the appropriate orientation of the catalytic tyrosine of the loop 
and disrupts its basicity by expelling the Arg19/Arg17 side-chain from the active site. These results were 
supported by the resolution of the crystal structure of several binary complexes (PDB 2XB8, 2XB9, etc.). 
These results allowed us to solve the structure of the loop in Mt-DHQ2 for the first time because its 




To obtain further evidence supporting the role of Asp88*/Asp89* as a general base in the enzymatic 
mechanism reported here, the catalytic activity of D88N variant was studied in a pH range of 7.09.0 to 
show that the dehydratation reaction takes place if the catalytic tyrosinate is generated, by the buffer in this 
case. It is important to highlight that DHQ2 enzymes show a pH-dependence for Km and kcat, which 
increases sharply above pH 9 [13]. The maximum range of activity was found between pH 7.88.2. Using 
large large quantities of D88N variant and at pH 8.0, the Km and kcat values were determined and the 
enzymatic conversion was also monitored by 
1
H NMR (see Supplementary Online Data). The significant 
reduced affinity for the substrate is not surprinsing considering that Asp88* is also involved in the 
recognition of the C4 hydroxyl group of the substrate. In addition, the fact that the D88N variant is a trimer 
rules out the possibility of a major structural change at the monomer interfaces that we have studied. 
Moreover, considering that 0.5 M guanidinium chloride dissociates wild-type Mt-DHQ2 into trimers that 
retain their enzymatic activity [13], it is unlikely that the observed loss of activity in the D88N variant is a 
consequence of its trimeric state. Therefore, we think that the site-directed mutagenesis studies and the pH 
effect studies with D88N variant demonstrate the essentially of Asp88* as a general base in the enzymatic 
mechanism, in line with the results from our QM/MM studies. In addition, the decreased catalytic activity of 
the N12S variant enzyme also confirms that the conserved Asn12 is likely to have a role beyond establishing 
a hydrogen-bonding interaction with the conserved water molecule. 
On the other hand, similar substrate isotope effects on Vmax and Vmax/Km reported earlier for Mt-DHQ2 and 
An-DHQ2 suggested that hydrogen abstraction is, at least partially, the rate-determining step of the reaction 
and that it occurs at or before the highest energy barrier leading to the transition state(s) [16]. However, 
important differences between both enzymes were found in the solvent isotope and proton inventory studies 
reported. For Mt-DHQ2, no solvent isotope effect on Vmax/Km was obtained and a single exchangeable 
proton in the reaction was found that is associated with the elimination step. On the contrary, for An-DHQ2, 
a solvent isotope effect on Vmax/Km was observed and at least two protons transferred from water or two 
water-exchangeable groups were found to be involved in the reaction. These previously reported 
experimental results were in nice agreement with our theoretical findings and we thought they might well 
relate to the catalytic water molecule involved in the reaction. The results from solvent isotope effects and 
proton inventory studies reported here showed that, for Hp-DHQ2, there are at least two protons involved in 
the reaction, one associated with the elimination step and another/others involved in tyrosine deprotonation, 
in agreement with the QM/MM proposal that a water molecule assists in Tyr deprotonation. For Mt-DHQ2, 
on the contrary, a single proton contributing to the observed effect confirms that the reaction catalyzed by 
this enzyme is not assisted by a water molecule. 
In conclusion, the results reported here strongly support a catalytic mechanism consisting of abstraction of 
the axial hydrogen of the substrate by the essential Tyr22/Tyr24, enolate formation that is stabilized by the 
positively charged side chain of the essential Arg17/Arg19, and β-dehydration mediated by the conserved 
His102/His101 acting as a proton donor. No evidence is found for an earlier suggestion of proton transfer 
from the side chain of Asn10/Asn12 to a water molecule but, instead, a previously unnoticed key role for 
Asp89*/Asp88* from a symmetry-related neighboring enzyme subunit in the reaction is proposed. The 
essentiality of this residue is supported by results from site-directed mutagenesis. Thus, Asp89*/Asp88* is 
not only involved in the formation of intersubunit electrostatic interactions with the conserved 
Arg113/Arg112 and also with the C4 hydroxyl group of the substrate, as previously suggested. 
Asp89*/Asp88* turns out to be the residue responsible for the deprotonation of the essential Tyr22/Tyr24 to 
afford the catalytic tyrosinate, which triggers the enzymatic process. For the Hp-DHQ2 enzyme, this 
deprotonation takes place through the assistance of a water molecule, while for Mt-DHQ2, Tyr24 is directly 
deprotonated by Asp88*. The participation of a water molecule in this deprotonation reaction is supported 
by solvent isotope effects and proton inventory studies. Site-directed mutagenesis studies also confirmed the 
important role of the conserved Asn10/Asn12 in stabilizing the neutral form of Asp89*/Asp88* in the 
enolate generation step as the QM/MM studies suggested.  
Our simulations also pinpoint the essential Arg17/Arg19 as the residue that most contributes to expel the 
product from the active site following a large conformational change involving residues 101112 and 
126130 which contain the conserved Arg108, Glu109 and Arg112 (for Mt-DHQ2). These findings reveal a 




motions for the catalytic turnover. Moreover, the key catalytic role played by Asp89*/Asp88* suggests that 
blocking this residue could be a useful strategy in the structure-based design of novel inhibitors of this 
attractive bacterial target. 
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Scheme 1 Enzymatic conversion of 3-dehydroquinic acid (1) to 3-dehydroshikimic acid (2)   
Previously proposed reaction mechanism of the reaction catalyzed by DHQ2. Proposed reaction 





Figure 1 Hp-DHQ2: Michaelis complex and proposed reaction mechanism  
Relevant residues are indicated and labeled. Hydrogen bonds are shown as dashed red lines. Note how 
Asp89* from a symmetry-related neighboring enzyme subunit is responsible, assisted by a water molecule 






   
   
Figure 2 Transition states TS1 and TS2 and enolate intermediate 3 geometries 
Representative shapshots of transition states TS1 (a,d) and TS2 (c,f), and enolate intermediate 3 (b,e) 
geometries along the reaction pathway of Hp-DHQ2 (blue) and Mt-DHQ2 (pink) enzymes. Relevant 







Figure 3 Generation of the catalytic tyrosinate in Mt-DHQ2 
Proposed mechanism for the deprotonation of the essential tyrosine (Tyr24) by Asp88* from a symmetry-





    
     
    
Figure 4 Product release 
Snapshots of 3-dehydroshikimic acid (2) (yellow) release from the active site of Mt-DHQ2 obtained from 
the MD simulations: a) superposition of results of the second reaction coordinate and previous MD 
simulation (purple) and after 10 ns of simulation at 25 °C (yellow); b) after 10 ns at 25 °C and 20 ns at 77 °C 
(green); c) after 10 ns at 25 °C and 36 ns at 77 °C (blue); d) after 10 ns at 25 °C and 37 ns at 77 °C; e) a 
general view of how the product exits the active site; f) superposition of 10 ns at 25 °C and 40 ns at 77 °C. 
Note the large conformational changes of residues 101112 and 126130 during product release. Relevant 
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